Literature DB >> 15528096

The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease.

Sean J Colloby1, John T O'Brien, John D Fenwick, Michael J Firbank, David J Burn, Ian G McKeith, E David Williams.   

Abstract

Dopaminergic loss can be visualised using (123)I-FP-CIT single photon emission computed tomography (SPECT) in several disorders including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Most previous SPECT studies have adopted region of interest (ROI) methods for analysis, which are subjective and operator-dependent. The purpose of this study was to investigate differences in striatal binding of (123)I-FP-CIT SPECT using the automated technique of statistical parametric mapping (SPM99) in subjects with DLB, Alzheimer's disease (AD), PD and healthy age-matched controls. This involved spatial normalisation of each subject's image to a customised template, followed by smoothing and intensity normalisation of each image to its corresponding mean occipital count per voxel. Group differences were assessed using a two-sample t test. Applying a height threshold of P <or= 0.05 corrected, the SPM[t] maps showed a significant bilateral reduced uptake in caudate, anterior and posterior putamen in DLB and PD subjects compared to AD subjects and controls. Significant reduction in binding was also observed bilaterally in the caudate nucleus in AD compared to controls. Striatal binding was indistinguishable between patients with DLB and PD. To investigate the usefulness of SPM as a decision aid in the evaluation of visually rated normal and abnormal patterns of uptake, receiver operator characteristic (ROC) curve analysis was performed using data from single-subject SPMs. The areas under the ROC curves were greater than 0.92, demonstrating comparable discriminatory power with visual rating. The automated voxel-based approach is a viable alternative to the subjective and often time-consuming method of ROI and, in addition, may have the potential to differentiate between normal and abnormal patterns of uptake in a manner similar to visual inspection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528096     DOI: 10.1016/j.neuroimage.2004.06.045

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  19 in total

Review 1.  SPECT imaging evaluation in movement disorders: far beyond visual assessment.

Authors:  Kosmas Badiavas; Elisavet Molyvda; Ioannis Iakovou; Magdalini Tsolaki; Kyriakos Psarrakos; Nikolaos Karatzas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-02       Impact factor: 9.236

2.  Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.

Authors:  Sean J Colloby; E David Williams; David J Burn; Jim J Lloyd; Ian G McKeith; John T O'Brien
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06-02       Impact factor: 9.236

3.  Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.

Authors:  Haruo Hanyu; Soichiro Shimizu; Kentaro Hirao; Hidekazu Kanetaka; Toshihiko Iwamoto; Taishiro Chikamori; Yasuhiro Usui; Akira Yamashina; Kiyoshi Koizumi; Kimihiko Abe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-11-22       Impact factor: 9.236

Review 4.  Imaging of the dopaminergic system in differential diagnosis of dementia.

Authors:  Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

5.  Building a FP-CIT SPECT Brain Template Using a Posterization Approach.

Authors:  D Salas-Gonzalez; Juan M Górriz; Javier Ramírez; Ignacio A Illán; Pablo Padilla; Francisco J Martínez-Murcia; Elmar W Lang
Journal:  Neuroinformatics       Date:  2015-10

6.  Machine learning models for the differential diagnosis of vascular parkinsonism and Parkinson's disease using [(123)I]FP-CIT SPECT.

Authors:  I Huertas-Fernández; F J García-Gómez; D García-Solís; S Benítez-Rivero; V A Marín-Oyaga; S Jesús; M T Cáceres-Redondo; J A Lojo; J F Martín-Rodríguez; F Carrillo; P Mir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-08-14       Impact factor: 9.236

7.  Validation of Simple Quantification Methods for (18)F-FP-CIT PET Using Automatic Delineation of Volumes of Interest Based on Statistical Probabilistic Anatomical Mapping and Isocontour Margin Setting.

Authors:  Yong-Il Kim; Hyung-Jun Im; Jin Chul Paeng; Jae Sung Lee; Jae Seon Eo; Dong Hyun Kim; Euishin E Kim; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2012-08-02

8.  Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.

Authors:  Andrea Pilotto; Francesca Schiano di Cola; Enrico Premi; Roberto Grasso; Rosanna Turrone; Stefano Gipponi; Andrea Scalvini; Elisabetta Cottini; Barbara Paghera; Valentina Garibotto; Maria Cristina Rizzetti; Laura Bonanni; Barbara Borroni; Silvia Morbelli; Flavio Nobili; Ugo Paolo Guerra; Daniela Perani; Alessandro Padovani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-16       Impact factor: 9.236

9.  Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.

Authors:  Atsushi K Kono; Kazunari Ishii; Keitaro Sofue; Naokazu Miyamoto; Setsu Sakamoto; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-22       Impact factor: 9.236

10.  Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging.

Authors:  Enrico Premi; V D Calhoun; V Garibotto; R Turrone; A Alberici; E Cottini; A Pilotto; S Gazzina; M Magoni; B Paghera; B Borroni; A Padovani
Journal:  Mol Imaging Biol       Date:  2017-10       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.